Previous Section | Back to Table of Contents | Lords Hansard Home Page |
Baroness Cumberlege asked Her Majesty's Government:
Lord Hunt of Kings Heath: Although there is no fixed retirement age for general practitioners they are removed from the health authority medical list on reaching 70 years of age if providing general medical
services as a principal. Similarly doctors employed under the salaried doctor scheme cannot work past the age of 70. Numbers of GP principals who will reach the age of 70 in each of the next five years are set out in the table. However these do not take account of doctors who may retire before age 70 by choice or for medical or other reasons, nor is any allowance made for those GPs who may exercise the option to retire and so claim their pension and gratuity but who may return to the HA medical list 28 days later and continue working until they fully retire. In addition there is no retirement age for doctors employed in personal medical services pilots, as assistants or as locums.64 | 65 | 66 | 67 | 68 | 69 | 70 | |||
All UPEs | 27,591 | of which: | 198 | 117 | 94 | 83 | 69 | 48 | 0 |
of which: | |||||||||
GMS | 26,710 | 193 | 115 | 93 | 82 | 68 | 47 | 0 | |
PMS | 881 | 5 | 2 | 1 | 1 | 1 | 1 | 0 |
Note:
(2) UPEs includes Unrestricted Principals. PMS Contracted GPs and PMS Salaried GPs.
Source:
Department of Health General Medical and Personal Medical Services Statistics.
Lord Morris of Manchester asked Her Majesty's Government:
Lord Hunt of Kings Heath: No information is held centrally on the number of patients with haemophilia who received clotting factor made from plasma donated by the individual who later developed vCJD. Haemophilia centre directors were notified in December 2000 of the batch numbers of the clotting factor and are in the process of identifying the recipients from their patient records. The UK Haemophilia Doctors Association, in consultation with the Department of Health, has agreed a policy of giving all haemophilia patients information about the incident and offering them a choice to know if they or their children received the implicated clotting factor. Counselling and advice to patients will be provided by haemophilia centres. The Government have asked an expert panel to consider as a matter of urgency how such incidents should be managed in future.
In 1998, the Government took the step of ceasing to use UK plasma in the manufacture of blood products
Lord Morris of Manchester asked Her Majesty's Government:
Lord Hunt of Kings Heath: The inquiry into the matters arising from the deaths of Harold Shipman's patients is in the course of being established. It will consider evidence relevant to its terms of reference.
The Department of Health will of course co-operate with any request from the inquiry for disclosure of any information which it holds which is relevant to the terms of reference.
Baroness Cumberlege asked Her Majesty's Government:
Lord Hunt of Kings Heath: The merger of the Sexual Health and HIV Strategies led to slippage in the timetable but we plan to issue it shortly.
Lord Janner of Braunstone asked Her Majesty's Government:
Lord Hunt of Kings Heath: The information is not available in the form requested. However, a study Cost Effectiveness of Smoking Cessation Interventions by the Health Education Authority in collaboration with the University of York published in 1997 estimated the annual cost to the National Health Service of treating smoking related disease caused by smoking at between £1.4 billion and £1.7 billion for England. This is the most recent available estimate.
Lord Harris of Haringey asked Her Majesty's Government:
Lord Hunt of Kings Heath: The total allocation of funds for Community Health Councils in the past five years for five of the Regional Offices is set out as follows. The responsibilities of Regional Offices in supporting and managing CHCs are set out in guidance. All Regional Offices are adequately resourced to provide this function. Information on services in Wales is a matter for the National Assembly for Wales. Due to Regional Office organisation in 1999, the total allocation of funds for CHCs from the three Regional Offices concerned is set out from 1999.
Further to the recent report from Bio Products Laboratory that plasma from a person later found to have vCJD had been used in the manufacture of clotting factor for the treatment of National Health Service patients with haemophilia, how many people have been affected by the finding; what individual advice and counselling have been given to patients who may be affected; and what further action they are taking.[HL448]
Whether they will make information on the extent of the use of diamorphine in the treatment of "Do not Resuscitate" patients in National Health Service hospitals available to the public inquiry headed by Dame Janet Smith into the extent of Dr Shipman's unlawful activities.[HL376]
On what date the draft Sexual Health and HIV Strategy will be issued for consultation.[HL442]
What was the estimated cost to the National Health Service of treating people suffering from illness as a result of smoking in each of the last five years for which figures are available.[HL362]
What was the total allocation of funds to local Community Health Councils in each region in England and in Wales in each of the last five years; and what was the level of resources spent by each of the National Health Service Regional Offices and by the Welsh Office in supporting, servicing and supporting Community Health Councils in each of the last five years.[HL411]
North Thames
1996-97: £3,597,000
1997-98: £3,654,000
1998-99: £3,752,000
South Thames
1996-97: £3,350,000
1997-98: £3,872,000
1998-99: £3,938,000
London RO
1999-2000: £4,067,000
2000-01: £4,215,000
South West RO
1996-97: £1,925,000
1997-98: £1,957,000
1998-99: £2,000,900
29 Jan 2001 : Column WA40
Lord Rotherwick asked Her Majesty's Government:
For what purposes the £14 million allocated to Zimbabwe is intended to be used by the government of Zimbabwe in this financial year; and[HL120]
For what purposes the £14 million allocated to Zimbabwe is intended to be used by the government of Zimbabwe in the next financial year.[HL121]
Baroness Amos: I am writing in reply to your Questions laid before the House on 12 December 2000, I apologise for the delay in answering.
You asked Her Majesty's Government the following three questions: for what purpose they allocated £14 million to Zimbabwe in the last financial year; for what purposes the £14 million allocated to Zimbabwe is intended to be used by the Government of Zimbabwe in this financial year; and for what purposes the £14 million allocated to Zimbabwe is intended to be used by the Government of Zimbabwe in the next financial year.
Total DfID spend in Zimbabwe in 1999-2000 was £14,029,000. This, however, was rounded to produce the £14 million figure. The actual expenditure by major activity in Zimbabwe for the last financial year (1999-2000) and planned expenditure for the current financial year (2000-01) is best explained in the table which I attach at Appendix 1. The allocation for 2001-02 is £12 million. Major spending activities will
be broadly similar to those described for the current financial year.1999-2000 | 2000-2001 | |
Health and HIV/AIDS prevention | £3.5m | £6m |
Rural water and sanitation, livelihoods and non-governmental resettlement | £2.6m | £4m |
Reform of local government and agricultural services for smallholders. | £3.1m | £2m |
Governance and human rights | £1.3m | £0.9m |
Private sector development and privatisation | £1.3m | £0.7m |
Poverty studies and policy development | £0.2m | £0.4m |
Aid and Trade Provision | £1.5m | -- |
Cyclone Eline humanitarian relief | £0.2m | -- |
Education | £0.2m | -- |
Back to Table of Contents | Lords Hansard Home Page |